Evidence map›Paper›PMID 41048404›Full record

ArticleEuropean heart journal open2025

Prognostic significance of abdominal aortic calcification scores on dual-energy X-ray absorptiometry scans for mortality in cancer survivors: NHANES-based cohort study (2013-2019).

Mustafa Al-Jarshawi, Glen P Martin, Andrew Cole, Miguel Nobre Menezes, Richard K Cheng, Juan Lopez-Mattei, Eric H Yang, Mamas A Mamas

Abstract read
In one paragraph

Article in European heart journal open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mustafa Al-JarshawiKeele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Stoke-on-Trent, UK.ORCID https://orcid.org/0000-0002-4600-2701
Glen P MartinCentre for Health Informatics, Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.ORCID https://orcid.org/0000-0002-3410-9472
Andrew ColeKeele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Stoke-on-Trent, UK.ORCID https://orcid.org/0000-0002-9595-0003
Miguel Nobre MenezesStructural and Coronary Heart Disease Unit, Cardio-Oncology Unit CHULN Hospital de Santa Maria, Cardiovascular Center of the University of Lisbon, 1649-028 Lisbon, Portugal.
Richard K ChengDivision of Cardiology, University of Washington, Seattle, WA 98195-6422, USA.
Juan Lopez-MatteiDivision of Cardiology, Lee Health Heart Institute, Fort Myers, FL 33908, USA.
Eric H YangUCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Mamas A MamasKeele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Stoke-on-Trent, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Abdominal aortic calcification (AAC) is a marker of systemic atherosclerosis associated with adverse cardiovascular (CV) outcomes in the general population. This study aimed to evaluate the association of AAC with all-cause and CV mortality in cancer survivors. Methods and results: Using 7 years of data from the National Health and Nutrition Examination Survey (NHANES, 2013-2019), we analysed a nationally representative cohort of US cancer survivors. AAC burden was quantified using the Kauppila AAC-24 scores on dual-energy X-ray absorptiometry (DXA) scans. Kaplan-Meier curves and multivariable Cox models were used to assess the associations between AAC and all-cause mortality, while Fine and Gray models assessed associations between AAC and CV mortality, accounting for non-CV mortality as a competing risk. A total of 23 126 424 cancer survivors (aged ≥40 years) were analysed, recording 4 199 131 (114 unweighted) all-cause deaths and 1 160 618 (34 unweighted) CV deaths over a 69-month median follow-up. AAC was present in 46%, with 19.5% of the cohort showing severe AAC (AAC-24 > 6). Each one-unit increase in AAC-24 score was associated with higher risks of all-cause mortality and CV mortality [adjusted hazard ratio, 95% confidence interval of 1.04 (1.00-1.09) and subdistribution hazard ratio 1.07 (1.02-1.12); Conclusion: AAC detected on DXA scans is independently associated with increased all-cause and CV mortality in cancer survivors aged 40 years and older. DXA-based AAC assessment may serve as a valuable tool for risk stratification in cardio-oncology.

Indexed as

Abdominal aortic calcification (AAC)All-cause mortalityCancer survivorsCardio-oncologyCardiovascular mortalityDual-energy X-ray absorptiometry (DXA)

Identifiers

PMID41048404
PMCPMC12492483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.